Authors
Loading...
This review highlights therapeutic opportunities related to fibroblast activation protein in the tumour microenvironment, implying its role in immunotherapy outcomes.
Lee et al. (2025) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: